ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,069.61
      1.18%
      US Tech 100
      17,021.20
      1.60%
      Dow Jones
      38,483.20
      0.64%
      Brent Oil
      87.535
      1.30%
      Bitcoin
      66,462.28
      -0.58%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Celularity Inc (CELU)

      7. Celularity Inc (CELU) News

      CELU Celularity Inc

      3.26
      0.20 (6.54%)
      Last Updated: 15:11:37
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Celularity Inc CELU NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.20 6.54% 3.26 15:11:37
      Open Price Low Price High Price Close Price Prev Close
      3.04 3.04 3.36 3.06
      more quote information »

      Recent News

      Date Time Source Heading
      4/22/202408:00GLOBECelularity Inc. to Host Investor and Analyst Research &..
      4/19/202417:30GLOBECelularity Inc. Announces Receipt of Nasdaq Notice Regarding..
      4/18/202416:30GLOBECelularity Abstract “Emerging Technologies for the..
      4/15/202408:00GLOBECelularity Announces Net Sales Trending Ahead of..
      4/08/202409:00GLOBECelularity to Present Data Showing Senescent Cell..
      3/26/202409:00GLOBECelularity Receives Healthcare Common Procedure Coding..
      3/20/202409:15GLOBECelularity Submits Request to U.S. FDA for Orphan Drug..
      3/14/202409:15GLOBECelularity CEO to Present on Cell Therapy’s Potential to..
      3/12/202409:20GLOBECelularity CEO to Present Keynote Address at 2024 Society..
      3/07/202409:35GLOBECelularity to Present Data Showing Cancer Tumor Reduction by..
      2/26/202417:15EDGAR2Form 8-K - Current report
      2/23/202416:10GLOBECelularity Announces 1-for-10 Reverse Stock Split
      2/22/202409:05EDGAR2Form 8-K - Current report
      2/21/202421:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/21/202421:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/21/202421:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/21/202421:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/21/202421:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/14/202416:05GLOBECelularity’s Tri-layer Decellularized, Dehydrated Human..
      2/12/202416:15EDGAR2Form 8-K - Current report
      2/02/202406:01EDGAR2Form DEF 14A - Other definitive proxy statements
      2/01/202409:00GLOBECelularity Announces Net Sales Expectations for First..
      1/25/202409:00GLOBECelularity and Genting Leaders Comments on Closing $21..
      1/23/202406:02EDGAR2Form PRE 14A - Other preliminary proxy statements
      1/18/202413:40GLOBECelularity Releases CEO Letter to Shareholders
      1/17/202417:15EDGAR2Form SC 13D/A - General statement of acquisition of..
      1/17/202416:14EDGAR2Form 8-K - Current report
      1/09/202416:49EDGAR2Form 8-K - Current report
      1/04/202413:00GLOBECelularity Confirms Commercialization Agreement with..
      1/03/202412:00GLOBECelularity Announces Net Sales and Total Revenue..
      12/29/202316:47EDGAR2Form 8-K - Current report
      11/24/202313:46EDGAR2Form 8-K - Current report
      11/24/202313:15GLOBECelularity Inc. Announces Receipt of Nasdaq Notice Regarding..
      10/18/202309:00GLOBECelularity Announces Commercial Biomaterial Products..
      10/16/202320:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/16/202319:44EDGAR2Form 3 - Initial statement of beneficial ownership of..
      9/19/202309:25EDGAR2Form 8-K - Current report
      9/07/202316:21EDGAR2Form 8-K - Current report
      9/07/202316:10GLOBECelularity Appoints Geoffrey Shiu Fei Ling, M.D., Ph.D. to..
      8/29/202309:15EDGAR2Form 8-K - Current report
      8/29/202309:00GLOBECelularity Announces Multi-Year Research Collaboration..
      8/25/202316:06EDGAR2Form 8-K - Current report
      8/14/202317:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      8/04/202316:16EDGAR2Form 8-K - Current report
      7/28/202316:27EDGAR2Form 8-K - Current report
      7/28/202316:24EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      7/27/202309:07GLOBECelularity Inc. Announces $3 Million Registered Direct..
      7/27/202309:00GLOBECelularity and Verséa Ophthalmics Announce Exclusive U.S...
      7/19/202312:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/18/202309:00GLOBECelularity Human Placental-Derived Advanced Biomaterials..

      Your Recent History

      NASDAQ
      CELU
      Celularity
      Delayed Upgrade Clock